1. Home
  2. VSTS vs NRIX Comparison

VSTS vs NRIX Comparison

Compare VSTS & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSTS
  • NRIX
  • Stock Information
  • Founded
  • VSTS 1936
  • NRIX 2009
  • Country
  • VSTS United States
  • NRIX United States
  • Employees
  • VSTS N/A
  • NRIX N/A
  • Industry
  • VSTS
  • NRIX Biotechnology: Pharmaceutical Preparations
  • Sector
  • VSTS
  • NRIX Health Care
  • Exchange
  • VSTS Nasdaq
  • NRIX Nasdaq
  • Market Cap
  • VSTS 819.7M
  • NRIX 908.0M
  • IPO Year
  • VSTS N/A
  • NRIX 2020
  • Fundamental
  • Price
  • VSTS $6.14
  • NRIX $11.34
  • Analyst Decision
  • VSTS Sell
  • NRIX Strong Buy
  • Analyst Count
  • VSTS 4
  • NRIX 16
  • Target Price
  • VSTS $9.25
  • NRIX $29.56
  • AVG Volume (30 Days)
  • VSTS 3.0M
  • NRIX 1.0M
  • Earning Date
  • VSTS 08-06-2025
  • NRIX 07-09-2025
  • Dividend Yield
  • VSTS 1.71%
  • NRIX N/A
  • EPS Growth
  • VSTS N/A
  • NRIX N/A
  • EPS
  • VSTS N/A
  • NRIX N/A
  • Revenue
  • VSTS $2,731,558,000.00
  • NRIX $88,381,000.00
  • Revenue This Year
  • VSTS N/A
  • NRIX $34.87
  • Revenue Next Year
  • VSTS $0.36
  • NRIX N/A
  • P/E Ratio
  • VSTS N/A
  • NRIX N/A
  • Revenue Growth
  • VSTS N/A
  • NRIX 41.86
  • 52 Week Low
  • VSTS $5.20
  • NRIX $8.18
  • 52 Week High
  • VSTS $17.83
  • NRIX $29.56
  • Technical
  • Relative Strength Index (RSI)
  • VSTS 55.09
  • NRIX 50.52
  • Support Level
  • VSTS $5.75
  • NRIX $12.06
  • Resistance Level
  • VSTS $6.16
  • NRIX $13.00
  • Average True Range (ATR)
  • VSTS 0.28
  • NRIX 0.80
  • MACD
  • VSTS 0.06
  • NRIX -0.06
  • Stochastic Oscillator
  • VSTS 92.78
  • NRIX 23.76

About VSTS Vestis Corporation

Vestis Corp is a provider of uniform rentals and workplace supplies across the United States and Canada. It provides uniforms, mats, towels, linens, restroom supplies, first-aid supplies, safety products, and other workplace supplies. The Company serves customers ranging from small, family-owned operations with a single location to large corporations and national franchises with multiple locations. The company operates in the United States and Canada as reportable segments. The company earns the majority of its revenue from the United States.

About NRIX Nurix Therapeutics Inc. Common stock

Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies.

Share on Social Networks: